Understanding the Market
GLOBAL CANCER THERAPEUTICS MARKET
Worldwide, in 2020, there were (excluding non-melanoma skin cancer) an estimated 18 million cases of cancer and 10 million cancer deaths (GLOBCAN 2020 International Agency for Research on Cancer)
​
It is estimated that the global cancer therapeutics market will reach around USD 278 billion by 2027, growing at a CAGR of 7.5% during the forecast period.
​
The size of the market for ONKONEK is likely to be substantial given its broad applicability to a wide range of solid tumours and its potential minimal normal tissue toxicity
BIG PHARMA DEALS IN 2020 WITH BIOTECHS LIKE SYNTHERIX
GSK/IDEAVA for IDE397 to start phase I studies
(Total value $3,030M Upfront payment $100M)
MERCK/ Taiho KRAS inhibitor
(Total value $2,550 Upfront payment $50M)
ROCHE/Blueprint RET inhibitor Pralsetinib to start phase I/II clinical study
(Total value $1,720M Upfront payment $675M)